Publication

Importance of Low- and Moderate-Grade Adverse Events in Patients’ Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial

The role of low- and moderate-grade adverse events in patients’ treatment experience and treatment discontinuation in the E1912 trial.

O’Connell NS et al.
Journal of Clinical Oncology · 2024

View publication

Citation

O’Connell NS et al. Importance of Low- and Moderate-Grade Adverse Events in Patients’ Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial. Journal of Clinical Oncology. 2024;42(3):266–272. DOI.